Youcare Pharmaceutical Group Co. Ltd. A Cash Flow Conversion Efficiency

Latest as of December 2025: 0.051x

Youcare Pharmaceutical Group Co. Ltd. A cash flow conversion efficiency. Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥173.51 Million ≈ $25.39 Million USD) by net assets (CN¥3.43 Billion ≈ $502.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)

Cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Youcare Pharmaceutical Group Co. Ltd. A share price for real-time trading data and today's change.

Youcare Pharmaceutical Group Co. Ltd. A Cash Flow Conversion Ratio Explained

Youcare Pharmaceutical Group Co. Ltd. A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency. Also see Youcare Pharmaceutical Group Co. Ltd. A (688658) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS IS:ECILC	0.014x
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	0.004x
Tortoise Energy Infrastructure Closed Fund NYSE:TYG	0.017x
Salfacorp SN:SALFACORP	0.122x
Hangzhou Jiebai Group Co Ltd SHG:600814	0.048x
Hiecise Precision Equipment Co Ltd SHE:300809	0.040x
CTO Realty Growth Inc NYSE:CTO	0.030x
NEW HORIZ.HEAL. DL-00005 F:6YZ	N/A

Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)

The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. Review Youcare Pharmaceutical Group Co. Ltd. A free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.43 Billion ≈ $502.48 Million	CN¥344.00 Million ≈ $50.34 Million	0.100x	-18.05%
2024-12-31	CN¥3.58 Billion ≈ $524.59 Million	CN¥438.24 Million ≈ $64.13 Million	0.122x	-44.01%
2023-12-31	CN¥3.60 Billion ≈ $526.45 Million	CN¥785.49 Million ≈ $114.94 Million	0.218x	+820.23%
2022-12-31	CN¥4.00 Billion ≈ $584.90 Million	CN¥-121.17 Million ≈ $-17.73 Million	-0.030x	-123.11%
2021-12-31	CN¥3.93 Billion ≈ $574.66 Million	CN¥515.24 Million ≈ $75.40 Million	0.131x	-32.57%
2020-12-31	CN¥3.59 Billion ≈ $524.73 Million	CN¥697.66 Million ≈ $102.09 Million	0.195x	-32.65%
2019-12-31	CN¥1.12 Billion ≈ $164.59 Million	CN¥324.94 Million ≈ $47.55 Million	0.289x	+26.35%
2018-12-31	CN¥842.76 Million ≈ $123.32 Million	CN¥192.70 Million ≈ $28.20 Million	0.229x	-24.22%
2017-12-31	CN¥711.86 Million ≈ $104.17 Million	CN¥214.81 Million ≈ $31.43 Million	0.302x	--

About Youcare Pharmaceutical Group Co. Ltd. A

SHG:688658 China Biotechnology

Market Cap

$757.27 Million

CN¥5.17 Billion CNY

Market Cap Rank

#9819 Global

#2534 in China

Share Price

CN¥11.50

Change (1 day)

-1.20%

52-Week Range

CN¥10.64 - CN¥31.79

All Time High

CN¥34.33